Vitamin K2 selectively induces apoptosis of blastic cells in myelodysplastic syndrome: flow cytometric detection of apoptotic cells using APO2.7 monoclonal antibody

[1]  P. Roth,et al.  Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7. , 1997, Cytometry.

[2]  A. Gotoh,et al.  Establishment of a novel B-lymphoma cell line, CTB-1, with strong Pas antigen expression having chromosomal translocation (14;22). , 1997, International journal of oncology.

[3]  Z. Ao,et al.  A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. , 1996, Journal of immunology.

[4]  Marie-Cécile Michallet,et al.  Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Societe Francaise de Greffe de Moelle , 1996 .

[5]  J. Kerns,et al.  Growth Inhibition of Hepatoma Cells Induced by Vitamin K and Its Analogs (*) , 1995, The Journal of Biological Chemistry.

[6]  H. Zwierzina,et al.  Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG). , 1995, Leukemia.

[7]  Ziqiu Wang,et al.  The growth inhibitory effects of vitamins K and their actions on gene expression , 1995, Hepatology.

[8]  S. Hashimoto,et al.  Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukemia cell lines. , 1994, Biochemical and biophysical research communications.

[9]  W. J. Chen,et al.  Vitamin K3-induced cell cycle arrest and apoptotic cell death are accompanied by altered expression of c-fos and c-myc in nasopharyngeal carcinoma cells. , 1993, Oncogene.

[10]  C. Haanen,et al.  Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia , 1990, Cancer.

[11]  Y. Masuda,et al.  Geranylgeraniol is a potent inducer of apoptosis in tumor cells. , 1995, Journal of biochemistry.

[12]  N. Schmitz,et al.  Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes. , 1992, Hematology/oncology clinics of North America.

[13]  C. Kessler,et al.  Sensitive chemiluminescent detection of digoxigenin-labeled nucleic acids: a fast and simple protocol and its applications. , 1992, BioTechniques.